Statistics from Altmetric.com
To the editor: In their review on statin use in controversial subgroups, Drs Jukema and Bergheanu1 comment on the protective role of statin treatment in the elderly at risk for cardiovascular events. We do not share that same optimism, since statin treatment in this group has increased cancer at the expense of decreasing cardiovascular disease. Moreover, recent investigations offer insight into why this might occur.
Importantly, the PROspective Study of Pravastatin …